Ledipasvir and Sofosbuvir Tablets

60 USD ($)

Get a Price/Quote

Product Details:

Dosage As Directed By Physician.
Dosage Guidelines As Directed By Physician.
Suitable For Adults
Storage Instructions Store in a cool and dark place.
Supply Ability : 1000000 Box Per Month
Click to view more
Share Your Product:

Ask A Question Send Inquiry

Product Details
Product Description

Price And Quantity

Price 60 USD ($)
Minimum Order Quantity As required by client. Box

Product Specifications

Storage Instructions Store in a cool and dark place.
Dosage As Directed By Physician.
Suitable For Adults
Dosage Guidelines As Directed By Physician.

Trade Information

FOB Port Hazira / Nhava Sheva
Payment Terms Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)
Supply Ability 1000000 Box Per Month
Delivery Time 1-2 Week
Sample Available Yes
Sample Policy If order is confirmed we will reimburse the sample cost
Main Export Market(s) Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Certifications WHO-GMP/ GMP/ COA/ As Required By Client

Product Description

Product Details:

Brand

SOFOCRUZ LP

We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of SOFOCRUZ LP TABLET (Sofosbuvir 400mg + Ledipasvir 90mg ) in different strength and packing. Our manufacturing facility is certified with WHO-GMP.

COMPOSITION :

SOFOCRUZ LP TABLET (Sofosbuvir 400mg + Ledipasvir 90mg )

Brand name: SOFOCRUZ LP
Active Ingredients(Generic Name) : Sofosbuvir 400mg + Ledipasvir 90mg
Company Name: Torrent Pharmaceuticals Ltd
Strength : 400 mg + 90 mg
Package: 28 tabs
Pack Type: Bottle

Indication:

SOFOCRUZ LP Contain Sofosbuvir and Ledi pasvir For the treatment of Hepatitis C.
Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

The hepatitis C virus is a blood borne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130-150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however, research in this area is ongoing.

The hepatitis C virus is a blood borne virus. It is most commonly transmitted through:

injecting drug use through the sharing of injection equipment;
the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
The transfusion of unscreened blood and blood products.

Uses:-
Treating chronic hepatitis C virus (HCV) infection in certain patients.
Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.

Available other Brand: HEPCINAT LP, LEDIFOS, RESOF L, LEDVICLEAR, MYHEP LVIR, HEPCVIR L, SOFOCURE L, NOVISOF L, LEDIHEP, SOFAB LP, LEDVICLEAR, SOFOKEM L, CIMIVIR